Hints and tips:
Related Special Reports
US pharma group follows Eli Lilly with website for patients to obtain medication online
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...AstraZeneca’s chair Michel Demaré told the FT last year that the company was prepared to endure “major criticism” over his pay package in order to keep hold of Soriot....
...another contract manufacturer, said it had received “exploratory inquiries” about “potential supply chain resiliency challenges”, following talks over the Biosecure Act and the acquisition in February of major...
...“The profile of the antibodies made by our vaccine is very similar to the validated antibody drugs and this was probably a major driver of a deal,” said Pfeifer....
...On the day of Xaira’s launch, BenevolentAI announced major lay-offs....
...The early-stage plans are the latest effort by a pharmaceutical company to circumvent industry middlemen and sell drugs directly to US patients....
...The company’s last major acquisition was the $16.6bn takeover of heart device maker Abiomed in November 2022....
...The partnership strengthens Sanofi, one of the world’s largest vaccine makers by sales, in the post-pandemic Covid jab market, where pharmaceutical groups are increasingly focused on combined shots against...
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
Drugmaker could fast track subsidiary’s bankruptcy process if 75% of claimants vote in favour of new plan
...Vaccine hopes and demand for medical treatments also buoyed pharmaceutical groups such as Moderna and Pfizer in 2020, as well as lesser-known Chinese groups, including WuXi Biologics, Chongqing Zhifei Biological...
A company launched in 1963 confronts challenge of adapting to the rise of anti-obesity injections
Admonitions about staff trading in their employer’s shares may now need to be broadened
...Lab monkey prices in China have plummeted as a post-pandemic slowdown in drug development ripples through the pharmaceutical sector in the world’s second-largest economy....
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
...China is one of the world’s largest makers of active pharmaceutical ingredients and antibiotics and a major supplier of drugs to the EU and US....
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...The franc was the strongest-performing major currency of 2023 and has hit Switzerland’s exporters such as Roche, which makes most of its sales in the US....
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
A weight loss titan fights to stay relevant in the age of GLP-1 drugs
...But compared with other major investments, scientific breakthroughs come cheap....
...In a statement on Thursday, the UK-based pharmaceutical company said that it would pay a $3.10-per-share dividend for 2024, 20 cents above the 2023 payout, “underlining the company’s confidence in its performance...
International Edition